BenQ Medical Technology Corp.(TW:4116)
NT$40.70-0.25 (-0.61%)
TW:4116
BenQ Medical Technology Corp. financials statements
NT$40.70
At close:-0.25 (-0.61%)
BenQ Medical Technology Corp. (4116) Ratios
BenQ Medical Technology Corp. Ratios
TW:4116's free cash flow for Q2 2026 was NT$140.63M. For the 2026 fiscal year, TW:4116's free cash flow was decreased by NT$-7.88M and operating cash flow was NT$148.51M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.62 | 1.75 | 1.99 | 1.72 | 1.88 |
| Quick Ratio | 1.23 | 1.31 | 1.61 | 1.46 | 1.42 |
| Cash Ratio | 0.42 | 0.49 | 0.60 | 0.65 | 0.80 |
| Solvency Ratio | 0.11 | 0.12 | 0.14 | 0.22 | 0.15 |
| Operating Cash Flow Ratio | 0.16 | 0.13 | 0.32 | 0.38 | 0.26 |
| Short-Term Operating Cash Flow Coverage | 0.32 | 0.33 | 1.13 | 2.36 | 1.42 |
| Net Current Asset Value | NT$ 572.75M | NT$ 124.76M | NT$ 200.51M | NT$ 60.04M | NT$ 14.67M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.36 | 0.36 | 0.33 | 0.25 | 0.25 |
| Debt-to-Equity Ratio | 1.77 | 1.70 | 1.43 | 0.71 | 0.47 |
| Debt-to-Capital Ratio | 0.64 | 0.63 | 0.59 | 0.42 | 0.32 |
| Long-Term Debt-to-Capital Ratio | 0.32 | 0.44 | 0.43 | 0.25 | 0.24 |
| Financial Leverage Ratio | 4.84 | 4.70 | 4.28 | 2.83 | 1.88 |
| Debt Service Coverage Ratio | 0.42 | 0.75 | 1.22 | 2.52 | 1.73 |
| Interest Coverage Ratio | 7.67 | 9.74 | 13.08 | 13.26 | 12.54 |
| Debt to Market Cap | 0.30 | 0.73 | 0.43 | 0.20 | 0.28 |
| Interest Debt Per Share | 16.35 | 43.70 | 35.88 | 19.42 | 11.12 |
| Net Debt to EBITDA | 1.70 | 1.69 | 1.19 | 0.43 | 0.73 |
| Profitability Margins | |||||
| Gross Profit Margin | 32.16% | 30.38% | 29.58% | 29.15% | 34.98% |
| EBIT Margin | 6.52% | 7.63% | 8.71% | 9.77% | 4.49% |
| EBITDA Margin | 11.64% | 12.98% | 13.75% | 16.15% | 11.38% |
| Operating Profit Margin | 6.52% | 6.99% | 8.04% | 6.07% | 3.35% |
| Pretax Profit Margin | 6.37% | 6.91% | 6.83% | 9.31% | 4.22% |
| Net Profit Margin | 1.49% | 2.20% | 2.52% | 6.11% | 1.97% |
| Continuous Operations Profit Margin | 4.14% | 4.98% | 4.41% | 8.02% | 3.35% |
| Net Income Per EBT | 23.36% | 31.83% | 36.94% | 65.57% | 46.68% |
| EBT Per EBIT | 97.71% | 98.80% | 84.88% | 153.46% | 125.94% |
| Return on Assets (ROA) | 1.43% | 1.99% | 2.43% | 5.30% | 1.47% |
| Return on Equity (ROE) | 6.94% | 9.34% | 10.42% | 15.04% | 2.78% |
| Return on Capital Employed (ROCE) | 10.79% | 9.51% | 10.95% | 7.47% | 3.29% |
| Return on Invested Capital (ROIC) | 5.05% | 5.63% | 6.20% | 5.29% | 2.42% |
| Return on Tangible Assets | 1.56% | 2.15% | 2.62% | 5.55% | 1.54% |
| Earnings Yield | 1.43% | 5.00% | 3.97% | 6.32% | 1.95% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.37 | 5.20 | 5.37 | 3.47 | 7.09 |
| Payables Turnover | 5.87 | 5.32 | 6.05 | 4.83 | 6.40 |
| Inventory Turnover | 3.99 | 4.24 | 6.20 | 7.83 | 4.50 |
| Fixed Asset Turnover | 7.26 | 4.06 | 4.25 | 3.16 | 1.97 |
| Asset Turnover | 0.96 | 0.90 | 0.96 | 0.87 | 0.75 |
| Working Capital Turnover Ratio | 3.83 | 3.55 | 4.37 | 5.23 | 4.10 |
| Cash Conversion Cycle | 97.21 | 87.66 | 66.50 | 76.19 | 75.49 |
| Days of Sales Outstanding | 67.93 | 70.20 | 68.01 | 105.10 | 51.47 |
| Days of Inventory Outstanding | 91.43 | 86.12 | 58.84 | 46.63 | 81.02 |
| Days of Payables Outstanding | 62.15 | 68.67 | 60.36 | 75.54 | 57.00 |
| Operating Cycle | 159.36 | 156.33 | 126.85 | 151.73 | 132.49 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2.88 | 5.01 | 9.92 | 8.50 | 2.72 |
| Free Cash Flow Per Share | 2.09 | 1.05 | 6.93 | 7.15 | 2.04 |
| Dividend Paid and CapEx Coverage Ratio | 2.08 | 0.84 | 1.95 | 4.60 | 1.62 |
| Capital Expenditure Coverage Ratio | 3.61 | 1.27 | 3.31 | 6.31 | 4.01 |
| Operating Cash Flow Coverage Ratio | 0.18 | 0.12 | 0.28 | 0.44 | 0.25 |
| Operating Cash Flow to Sales Ratio | 0.07 | 0.05 | 0.10 | 0.13 | 0.08 |
| Free Cash Flow Yield | 4.73% | 2.23% | 10.71% | 11.17% | 6.16% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 25.20 | 20.00 | 25.18 | 15.84 | 51.08 |
| Price-to-Sales (P/S) Ratio | 1.04 | 0.44 | 0.63 | 0.97 | 1.01 |
| Price-to-Book (P/B) Ratio | 4.87 | 1.87 | 2.62 | 2.38 | 1.42 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 21.13 | 44.84 | 9.34 | 8.95 | 16.24 |
| Price-to-Operating Cash Flow Ratio | 15.29 | 9.43 | 6.52 | 7.53 | 12.19 |
| Price-to-Earnings Growth (PEG) Ratio | -0.97 | -2.45 | -0.69 | 0.03 | -0.96 |
| Enterprise Value Multiple | 10.67 | 5.07 | 5.80 | 6.41 | 9.60 |
| Enterprise Value | 6.52B | 3.14B | 3.63B | 3.06B | 1.60B |
| EV to EBITDA | 10.67 | 5.07 | 5.80 | 6.41 | 9.60 |
| EV to Sales | 1.24 | 0.66 | 0.80 | 1.04 | 1.09 |
| EV to Free Cash Flow | 25.14 | 67.15 | 11.74 | 9.59 | 17.58 |
| EV to Operating Cash Flow | 18.18 | 14.12 | 8.20 | 8.07 | 13.19 |
| Tangible Book Value Per Share | 15.31 | 42.91 | 41.40 | 31.15 | 22.73 |
| Shareholders’ Equity Per Share | 9.06 | 25.27 | 24.67 | 26.90 | 23.30 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.35 | 0.28 | 0.35 | 0.14 | 0.21 |
| Revenue Per Share | 42.25 | 107.38 | 101.90 | 66.22 | 32.87 |
| Net Income Per Share | 0.63 | 2.36 | 2.57 | 4.04 | 0.65 |
| Tax Burden | 0.23 | 0.32 | 0.37 | 0.66 | 0.47 |
| Interest Burden | 0.98 | 0.91 | 0.78 | 0.95 | 0.94 |
| Research & Development to Revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 |
| SG&A to Revenue | 0.22 | 0.23 | 0.21 | 0.22 | 0.29 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.07 | 0.67 | 3.86 | 1.38 | 1.96 |
Currency in TWD
